Home/Case studies/Dual-chamber leadless pacing

A new class of device, on the registry from its first day in Ireland.

On 29 April 2026 the Mater Misericordiae University Hospital completed Ireland's first dual-chamber leadless pacemaker system. The case was captured on HRI's national registry during the procedure, not entered afterwards.

What happened

Dual-chamber leadless pacing uses two separate intracardiac devices, one atrial and one ventricular, that communicate wirelessly and work as a single therapeutic unit. It removes the main limitation that had kept leadless pacing to single-chamber use.

At the Mater, the atrial leadless component had been implanted in an earlier procedure, which was also captured on HRI. The April procedure added the ventricular component and enabled communication between the two, completing the system. The whole pathway, from the first implant to completion, is recorded longitudinally on the registry.

Why the registry had to change on the day

Two physically separate devices that function together as one system is a configuration a device registry has not had to represent before. HRI's technical team worked with the implanting centre during the procedure so that the registry's data model could record it properly.

That matters because the modelling decisions made when a device class first enters practice shape how every later case is recorded, followed and analysed.

The questions that come next are longitudinal

How does battery longevity behave over years of varied pacing burden, given the energy cost of continuous device-to-device communication? How do thresholds drift in real-world programming? What do retrieval and replacement look like at scale? These are questions that become far more powerful to study at national longitudinal scale, provided capture starts with the first case.

What it shows about the platform

  • Capture happens in the clinical workflow, during the procedure, by the implanting team.
  • The data model can be extended for a new device category without breaking the longitudinal record.
  • Earlier and later procedures for the same patient join up as one pathway.
  • Real-world evidence for a new technology begins at adoption, not in a retrospective study.
National registries only work when implanting centres treat data capture as part of the procedure, not as an afterthought. The Mater team set the standard.
Robert Kelly, Founder and CEO, Heart Rhythm International, with thanks to Professor Kevin Walsh, Ray Conboy, Emmet O'Connor and the electrophysiology team at the Mater

See an implant recorded end to end.

We will register a device by barcode and file the report, on demonstration data.